GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 826 - 850 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgA Patient 2 3 mild
G78255UI
613
IgG Patient 2 3 mild
G78255UI
205
IgM Patient 2 3 mild
G78255UI
409
IgA Patient 3 -180 mild
G78255UI
310
IgA Patient 3 11 mild
G78255UI
487
IgG Patient 3 -180 mild
G78255UI
42
IgM Patient 3 -180 mild
G78255UI
99
IgA Patient 3 4 mild
G78255UI
543
IgG Patient 3 11 mild
G78255UI
48
IgG Patient 3 4 mild
G78255UI
51
IgM Patient 3 11 mild
G78255UI
140
IgM Patient 3 4 mild
G78255UI
160
IgA Patient 4 12 mild
G78255UI
397
IgG Patient 4 12 mild
G78255UI
55
IgM Patient 4 12 mild
G78255UI
148
IgA Patient 1 10 moderate
G78074HX
374
IgA Patient 1 22 moderate
G78074HX
341
IgA Patient 1 6 moderate
G78074HX
342
IgG Patient 1 10 moderate
G78074HX
27
IgG Patient 1 22 moderate
G78074HX
33
IgM Patient 1 10 moderate
G78074HX
46
IgM Patient 1 22 moderate
G78074HX
69
IgG Patient 1 6 moderate
G78074HX
28
IgM Patient 1 6 moderate
G78074HX
41
IgA Patient 2 15 mild
G78074HX
243

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024